|
|
||||||||
Corresponding author: Holli A. DeVon, RN, PhD, Loyola University Chicago, Niehoff School of Nursing, 2160 S First Ave, Bldg 105, Maywood, IL 60153 (e-mail: hdevon{at}luc.edu).
| Abstract |
|---|
|
|
|---|
Objectives To detect differences between women and men in the type, severity, location, and quality of symptoms across the 3 clinical diagnostic categories of acute coronary syndromes (unstable angina, myocardial infarction without ST-segment elevation, and myocardial infarction with ST-segment elevation) while controlling for age, diabetes, functional status, anxiety, and depression.
Methods A convenience sample of 112 women and 144 men admitted through the emergency department and hospitalized for acute coronary syndromes participated. Recruitment took place at 2 urban teaching hospitals in the Midwest. Data were collected during structured interviews in each patients hospital room. Forty-eight symptom descriptors were assessed. Demographic characteristics, health history, functional status, anxiety, and depression levels also were measured.
Results Regardless of clinical diagnostic category, women reported significantly more indigestion (β = 0.25; confidence interval [CI] = 0.01–0.49), palpitations (β = 0.31; CI = 0.06–0.56), nausea (β = 0.37; CI = 0.10–0.65), numbness in the hands (β = 0.29; CI = 0.02–0.57), and unusual fatigue (β = 0.60; CI = 0.27–0.93) than men reported. Differences between men and women in dizziness, weakness, and new-onset cough did differ by diagnosis. Reports of chest pain did not differ between men and women.
Conclusions Women with acute coronary syndromes reported a higher intensity of 5 symptoms (but not chest pain) than men reported. Whether differences between the sexes in less typical symptoms are clinically significant remains unclear.
|
Notice to CE enrollees: A closed-book, multiple-choice examination following this article tests your understanding of the following objectives:
|
Although history, risk factor profile, findings on physical examination, stability of clinical manifestations, risk of a life-threatening complication, and diagnostic testing are equally important in the diagnosis and treatment of ACS, the symptom experience determines whether or not a person seeks treatment in an expeditious manner or seeks treatment at all. The symptom description also affects the care provided by emergency medical services personnel4–6 and emergency department triage nurses if emergency medical services personnel are not used.7
| Factors That May Influence Symptoms of ACS |
|---|
|
|
|---|
Age of the Patient
Numerous studies have substantiated that women are older than men when CHD is diagnosed.1 In the Third International Study of Infarct Survival Collaborative Group (ISIS-3) trial,20 among the 36 080 patients enrolled, women were significantly older than men when ACS was diagnosed. Differences between the sexes were examined in 12 142 patients participating in the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb (GUSTO IIb) study.21 Results indicated that women were a mean of 8 years older than were men (P < .001) when ACS was diagnosed. Perhaps differences in the symptoms of ACS can be explained by womens older ages rather than by their sex.
| Women with acute coronary syndromes have more back pain, dyspnea, indigestion, nausea and vomiting, and weakness than do men.
|
Diabetes
Diabetes was chosen as a variable for this study for several reasons. First, the prevalence of diabetes is significantly higher in women with ACS than in men with ACS. The ISIS-3 data20 indicated that women with acute myocardial infarction had diabetes more often than men had diabetes across all age groups. Similar findings were reported in the GUSTO IIb trial.21 First, the rate of diabetes in women was significantly higher than the rate in men at each level of ACS, including unstable angina, myocardial infarction without ST-segment elevation, and myocardial infarction with ST-segment elevation. Second, patients with diabetic neuropathy had impaired perception of cardiac pain.22 Patients with diabetes also had higher frequencies of silent exertional ischemia and silent myocardial infarction.23,24 Finally, diabetes is a powerful risk factor for CHD in both women and men; however, diabetes confers a 3- to 5-fold increase in risk of CHD mortality for women vs a 3-fold increase for men.25 We hypothesized that differences in symptoms between women and men, if present, would be explained by the higher prevalence of diabetes in women.
Mood Disorders
Mood disorders are a psychological factor that may help explain differences between women and men in symptoms of ACS. Depression is 3 times more common in women than in men and is a particularly serious problem in elderly women.26 An extensive review of prospective studies27,28 yields support for depression as a cardiac risk factor.
Mood disorders may also adversely affect the progression and outcome of CHD. Data have indicated that the presence of major depression in patients with a recent diagnosis of ACS more than doubled the risk of death due to cardiac disease.29 It has been hypothesized that the symptoms for depression and anxiety, particularly chest pain and tachycardia, can mimic the symptoms of ACS. This confounding clinical picture of similar symptoms between depression, anxiety, and ACS warrants further study.
| Goals of the Study |
|---|
|
|
|---|
| Nearly half of all patients indicated that symptoms were triggered by causes other than exertion, emotional upset, or rest.
|
Therefore, the purpose of our study was to determine if symptoms differed between women and men across the continuum of ACS diagnoses when age, diabetes, functional status, anxiety, and depression were controlled for. The specific aims were to do the following:
| Organizing Framework |
|---|
|
|
|---|
|
| Methods |
|---|
|
|
|---|
Patients were excluded if they had any history of cocaine use, documentation of prior heart failure, or elevated levels of brain natriuretic peptide. We hypothesized that the symptom experience might vary for patients with a history of cocaine use because ischemia in such patients is more likely to be precipitated by vasoconstriction, tachycardia, systemic hypertension, and increased myocardial oxygen consumption than by the more common and chronic pathophysiological processes associated with obstructive coronary artery disease.32 Patients with a history of heart failure were excluded because many of the symptoms of heart failure, including dyspnea and unusual fatigue, are similar to the symptoms of ACS.
Patients were not excluded if they had a history of ACS. It is not known if a history of ACS or stable CHD would affect the description of symptoms, although it is possible that prior knowledge of symptoms, experience with illness, or prior interventions would sensitize patients to somatic symptoms. After the patients were discharged, final diagnoses were retrieved from their medical records. Sixteen patients had a noncardiac discharge diagnosis (a code other than 410 or 411 in the International Classification of Diseases, Ninth Revision) and were excluded from analyses, resulting in a final sample of 112 women and 144 men (n = 256).
Instruments
The Symptoms of Acute Coronary Syndromes Inventory, the Canadian Cardiovascular Society (CCS) classification of angina, the Hospital Anxiety and Depression Scale, and a medical record review form developed for this study were used to collect data.
Symptoms of Acute Coronary Syndromes Inventory. The Symptoms of Acute Coronary Syndromes Inventory, based on an extensive review of the literature, was developed for a previous study on unstable angina.11 Published data reveal that the symptoms of ACS are a multidimensional construct. Consequently, the inventory consists of 3 parts describing the type, severity, location, and quality of symptoms. Part A includes 20 different symptoms described in the literature33–35 that may occur in patients with acute chest pain, myocardial infarction, or unstable angina. Symptoms are measured on a 5-point scale. Patients indicate that they either did not experience the symptom (0) or they rate the severity of each symptom as mild (1), moderate (2), severe (3), or very severe (4).
| Women had more pain in the jaw and neck than did men.
|
Part B includes 14 locations in the body where pain or discomfort may be experienced, and part C contains 14 descriptors of the quality of pain or discomfort. All items in parts B and C are measured dichotomously (yes/no). The content validity index for the entire instrument has been previously established at 0.88 (P < .05).11 Before the start of this study, the instrument was again reviewed by 5 content experts and the computed content validity index was 0.94 (P < .05).
| Chest pain was most frequently reported, but 21% of women and 10% of men experienced none.
|
Patients did not add additional symptoms when given the opportunity to do so during the interview, adding support for the construct validity of the instrument as a comprehensive measure of the symptoms of ACS. Finally, patients were asked about general characteristics of their symptoms, including the temporal nature of their pain, whether they treated symptoms, if they had ever experienced similar symptoms, what they thought triggered their symptoms, and the severity of their worst symptom.
CCS Classification of Angina. The CCS classification of angina was used to assess patients level of physical function.36 The reliability and validity of the classification system have been reported extensively.36 We hypothesized that patients in a higher CCS class would report more severe symptoms and a greater number of symptoms.
Hospital Anxiety and Depression Scale. The Hospital Anxiety and Depression Scale is a self-assessment tool designed to measure the 2 most common manifestations of mood disorders: anxiety and depression.37 The instrument includes 7 succinct questions for each subscale. Patients respond on a 4-point scale. The response items vary from question to question but essentially range from not at all to very often. In an attempt to avoid response bias, the order of responses is varied. The first response on some items indicates maximum severity and on others indicates minimum severity. The instrument has established reliability and validity for use in cardiovascular patients.38–40
| Absence of chest pain may lead to delayed or inadequate treatment.
|
Procedure
Data were collected from July 2003 to August 2005 after approval was received from the appropriate institutional review boards. A physician or a primary nurse approached each eligible patient and asked for permission to give the patients name to the researchers in accordance with the guidelines of the Health Insurance Portability and Accountability Act. When permission was obtained by hospital staff, a member of the research team approached the patient and explained the study. Written informed consent was obtained from patients who agreed to participate. Cognitive function was assessed during the consent process. All interviews were conducted in the patients hospital rooms. Instruments were designed to be self-administered; however, all responses were recorded by the investigators because of the acuteness of the patients illnesses.
The names of 282 patients were supplied by hospital staff. A total of 6 women and 4 men declined to participate because of fatigue, lack of interest, or refusal to sign the consent form. Of these 10 patients, 6 were black, and their ages were 40 to 85 years. The remaining 272 patients gave written consent and completed the interview. A total of 16 patients were excluded because they had a noncardiac discharge diagnosis; this exclusion resulted in a final sample of 256 patients.
Patients were asked to report only those symptoms that brought them to the emergency department on this admission. This restriction was used to reduce threats to internal validity caused by inclusion of prodromal symptoms, symptoms experienced during a previous episode of ACS, or symptoms that occurred as a result of another illness. Confidentiality was ensured because all patients rooms are private in the units where data were collected. Diagnoses, physical findings, test results, health history, and risk factors were abstracted from medical records at the conclusion of the interview.
Data Analyses
Data were coded and entered into SPSS, version 13 (SPSS Inc, Chicago, Illinois). All tests were 2-sided, and statistical significance was set at P = .05. Descriptive statistics were computed by using a
2 test for categorical data and t tests for interval level data. Simple linear regression was used to determine whether women and men differed in reported symptoms of ACS after clinical diagnosis, age, diabetes status, functional status, anxiety, and depression were controlled for. Logistic regression analyses were used to determine whether the sex of the patient was predictive of symptoms and to control for the same possible covariates. Model selection was used to find the best-fit model. This selection involved testing each of the covariates separately in a model that included the interaction between each patients sex and diagnosis. All covariates that were significant at the .20 level or less were included in the model, and backwards selection was used to identify the best model.
| Results |
|---|
|
|
|---|
2 = 5.12; P = .28) or levels of education (
2 = 7.14; P = .50). Women were more likely to have lower incomes (
2 = 19.41; P = .02) and to be unmarried (
2 = 40.4; P < .01; Table 1
|
2=1.55; P =.26). No significant differences between the sexes were found in prevalence of diabetes, hypertension, hyperlipidemia, exercise, family history of early CHD, or mean body mass index (index calculated as weight in kilograms divided by height in meters squared). Patients were placed into the following categories on the basis of mean body mass index: (1) underweight (index <18.5), (2) normal weight (18.5–24.9), (3) overweight (25–29.9), (4) obese (30–39.9), and (5) morbidly obese (>40). When analyzed categorically, women were more likely than men to be morbidly obese (
2 = 17.9; P = .01). Men were more likely than women to be current smokers (32% vs 21%;
2=4.17; P =.04). As expected, 79% of women were postmenopausal.
|
Anxiety and depression were assessed for the 2-week period preceding admission. Women scored significantly higher than men scored on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale. Mean anxiety scores were 7.71 (SD, 9.77) for women and 5.76 (SD, 3.66) for men (t = 2.21; P < .05). Mean depression scores were 5.02 (SD, 3.69) for women and 3.95 (SD, 3.92) for men (t = 2.22; P = .03). Although anxiety and depression scores were significantly different between men and women, the scores were not in the clinically significant range. According to Zigmond and Snaith,37 a score of 0 to 7 is not clinically significant, a score of 8 to 10 is borderline, and a score greater than 10 indicates a definite mood disorder.
Symptom Characteristics by Sex and Diagnosis
Most patients (61%) said their symptoms were constant; that they attempted to treat symptoms with home remedies (62%), most often acetaminophen; and that they had experienced similar symptoms in the past (57%). The data are broken down by the patients sex in Table 2
. Differences in these variables were not significant. Patients were asked if their symptoms were brought on by exertion, emotional upset, rest, or other causes (Table 2
). Men were more likely to report that their symptoms were brought on by exertion. Interestingly, more than half of all patients responded that symptoms were triggered by causes other than exertion, emotional upset, or rest.
Men reported more severe chest pain than women did, but mean scores did not differ significantly. Patients were also asked to rate the severity of the worst symptom on a scale of 1 to 10. This question was posed because not all patients experienced chest pain. Scores were higher in women, but the difference was not significant. Mean number of symptoms experienced was slightly higher for women than for men, but the difference was not significant. Symptom type, location, and quality were rank ordered to identify typical and atypical patterns for this cohort of patients. The 3 most frequently reported symptoms for both women and men were chest pain, unusual fatigue, and shortness of breath (Figure 2
). Although chest pain and shortness of breath are well known to clinicians and the general public as typical symptoms, unusual fatigue is not.
|
|
|
2=5.86; P =.02) and pain in the neck (
2=6.4; P = .01) than men reported. Women also were more likely than men to describe their chest pain as a feeling of fullness (
2 = 5.3; P = .03).
|
| Discussion |
|---|
|
|
|---|
Although men attributed the onset of their symptoms to exertion more frequently than women did, most women and men ascribed the onset of symptoms to other causes. The attribution of cause may influence how and when patients make a decision to seek emergent care or how to manage their disease once it is diagnosed.45 These issues require further exploration.
Our findings varied from those of previous studies10,11,13,16,17; we found no differences between women and men in back pain, dyspnea, nausea/vomiting, or weakness. Of note, in our study, women and men did not differ in the classic symptoms of chest pain, diaphoresis, and shortness of breath. Published reports have described equivocal findings about these symptoms. Some authors17 have reported that men experience more chest pain and diaphoresis, and others have indicated that women experience more shortness of breath10 and back pain.11 Still other authors,16 however, have found no differences.
Women in our study were more likely to experience indigestion, palpitations, nausea, numbness in the hands, and unusual fatigue that did not differ across diagnosis. Of note, these symptoms are considered atypical because they vary from those in the traditional male model, are vague, and are common to many less serious health problems. This situation puts both women and men at risk for delayed diagnosis and treatment if they do not experience typical symptoms with chest pain, but it confers greater risk to women in this sample, who experienced these symptoms more often. Differences between the sexes across diagnosis were minimal and most likely of no consequence.
As expected, chest pain was the most frequently reported symptom. However, the fact that 21% of women and 10% of men experienced no chest pain is a concern. Some evidence23,41,46,47 indicates that patients with silent ischemia are more likely to have the disease go undiagnosed or be misdiagnosed, are less likely to receive reperfusion therapy, and have poorer outcomes. Not surprisingly, patients with myocardial infarction with ST-segment elevation in the Global Registry of Acute Coronary Events (GRACE) study23 were less likely to receive percutaneous coronary intervention or fibrinolysis if their symptoms were atypical (no chest pain). It is possible that diagnosis and treatment might be compromised for those with unstable angina or myocardial infarction without ST-segment elevation because initial diagnosis is based on clinical presentation and history. Because the diagnosis of myocardial infarction with ST-segment elevation by means of electrocardiograms and cardiac markers is so straightforward, it may be assumed that treatment would not be affected by the initial symptoms. However, the GRACE findings suggest that the clinical features are equally important for all levels of ACS because diagnostic testing is a judgment call based on these features. Furthermore, GRACE findings indicate that the absence of chest pain may lead to delayed or inadequate treatment after presentation to the emergency department even for those experiencing myocardial infarction with ST-segment elevation.
Our results could facilitate the development of educational material to guide patients with atypical symptoms to seek care and an assessment tool that could be used by triage nurses in practice. Nurses are often patients first contact in the healthcare system and could speed up diagnostic testing, expedite appropriate treatments, and improve patients outcomes. Concise, evidence-based assessment tools could be developed to detect symptoms that are more likely for women, men, and patients with diabetes. Identification of the symptom differences described here and in prior studies could also lead to improved management of symptoms after discharge. The differences in symptoms for the 3 clinical diagnoses of ACS require further exploration to determine if the differences we found can be reproduced.
| Limitations |
|---|
|
|
|---|
In addition, the sample was restricted to patients who were admitted to the hospital with a diagnosis of ACS and therefore did not include patients who did not seek treatment or who had silent ischemia. Sampling bias is a limitation with the use of a convenience sample. This bias presents a potential threat to the internal validity of the findings. However, use of a probability sample is not possible in an acutely ill, hospitalized population. Strategies such as recruiting 7 days a week during a 12-hour period (8 AM to 8 PM) may have contributed to a more representative sample of the population than would otherwise occur with a convenience sample.
| ACKNOWLEDGMENTS |
|---|
eLetters
Now that youve read the article, create or contribute to an online discussion about this topic using eLetters. Just visit www.ajcconline.org and click "Respond to This Article" in either the full-text or PDF view of the article.
This research was supported by the National Institutes of Health, National Institute of Nursing Research, grant R15 NR08870.
| REFERENCES |
|---|
|
|
|---|
Related articles in AJCC:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |